PortfoliosLab logo

Regulus Therapeutics Inc. (RGLS)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$0.23
  • Year Range$0.16 - $1.26
  • EMA (50)$0.24
  • EMA (200)$0.45
  • Average Volume$2.19M
  • Market Capitalization$30.67M

RGLSShare Price Chart


Chart placeholderClick Calculate to get results

RGLSPerformance

The chart shows the growth of $10,000 invested in Regulus Therapeutics Inc. on Oct 5, 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $46 for a total return of roughly -99.54%. All prices are adjusted for splits and dividends.


RGLS (Regulus Therapeutics Inc.)
Benchmark (^GSPC)

RGLSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-8.00%-12.57%
YTD-28.12%-18.14%
6M-41.03%-17.07%
1Y-75.79%-5.21%
5Y-57.90%10.37%
10Y-42.92%10.76%

RGLSMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

RGLSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Regulus Therapeutics Inc. Sharpe ratio is -0.71. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


RGLS (Regulus Therapeutics Inc.)
Benchmark (^GSPC)

RGLSDividend History


Regulus Therapeutics Inc. doesn't pay dividends

RGLSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


RGLS (Regulus Therapeutics Inc.)
Benchmark (^GSPC)

RGLSWorst Drawdowns

The table below shows the maximum drawdowns of the Regulus Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Regulus Therapeutics Inc. is 99.94%, recorded on May 9, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.94%Nov 10, 20141887May 9, 2022
-53.26%Jul 12, 2013208May 8, 2014116Oct 22, 2014324
-25.98%Jan 3, 20138Jan 14, 201340Mar 13, 201348
-16.39%Apr 1, 201323May 1, 201319May 29, 201342
-15.76%Oct 26, 201233Dec 14, 20123Dec 19, 201236
-10.59%Jun 24, 20133Jun 26, 20134Jul 2, 20137
-6.53%Oct 9, 20122Oct 10, 20126Oct 18, 20128
-6.27%Nov 5, 20141Nov 5, 20142Nov 7, 20143
-4.66%Oct 28, 20141Oct 28, 20143Oct 31, 20144
-4.43%Mar 21, 20131Mar 21, 20131Mar 22, 20132

RGLSVolatility Chart

Current Regulus Therapeutics Inc. volatility is 286.24%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


RGLS (Regulus Therapeutics Inc.)
Benchmark (^GSPC)

Portfolios with Regulus Therapeutics Inc.


Loading data...

More Tools for Regulus Therapeutics Inc.